Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ticagrelor – toward more efficient platelet inhibition and beyond
Michał Kubisa, Mateusz P. Jeżewski, Aleksandra Gąsecka, et al.
Therapeutics and Clinical Risk Management (2018) Vol. Volume 14, pp. 129-140
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Antimicrobial Properties on Non-Antibiotic Drugs in the Era of Increased Bacterial Resistance
Maria Lagadinou, Maria Octavia Onisor, Athanasios Rigas, et al.
Antibiotics (2020) Vol. 9, Iss. 3, pp. 107-107
Open Access | Times Cited: 102
Progress in the clinical effects and adverse reactions of ticagrelor
Peng Wei, Xiaoqing Wang, Qiang Fu, et al.
Thrombosis Journal (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Ticagrelor attenuates the increase of extracellular vesicle concentrations in plasma after acute myocardial infarction compared to clopidogrel
Aleksandra Gąsecka, Rienk Nieuwland, Monika Budnik, et al.
Journal of Thrombosis and Haemostasis (2019) Vol. 18, Iss. 3, pp. 609-623
Open Access | Times Cited: 57
Antiplatelet drugs: Potential therapeutic options for the management of neurodegenerative diseases
Samir Kumar Beura, Rishika Dhapola, Abhishek Panigrahi, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 6, pp. 1835-1877
Closed Access | Times Cited: 20
Drugs targeting adenosine signaling pathways: A current view
Barbara Kutryb-Zając, Ada Kawecka, Khrystyna Nasadiuk, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115184-115184
Open Access | Times Cited: 17
Endothelial cells, neutrophils and platelets: getting to the bottom of an inflammatory triangle
Tima Dehghani, Alyssa Panitch
Open Biology (2020) Vol. 10, Iss. 10
Open Access | Times Cited: 46
Role of NF-κB in Platelet Function
Kevin Kojok, Abed El-Hakim El-Kadiry, Yahye Merhi
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 17, pp. 4185-4185
Open Access | Times Cited: 42
Systemic Design and Evaluation of Ticagrelor-Loaded Nanostructured Lipid Carriers for Enhancing Bioavailability and Antiplatelet Activity
Gi-Ho Son, Young‐Guk Na, Hyun Wook Huh, et al.
Pharmaceutics (2019) Vol. 11, Iss. 5, pp. 222-222
Open Access | Times Cited: 41
Mitochondrial Effects of Common Cardiovascular Medications: The Good, the Bad and the Mixed
Alina M. Bețiu, Lavinia Noveanu, Iasmina M. Hâncu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13653-13653
Open Access | Times Cited: 22
Temporal trends of atrioventricular block in acute coronary syndrome patients from the ACSIS registry
Shir Tal, Alon Barsheshet, Gal Sella, et al.
Heart Rhythm O2 (2025)
Open Access
Controlled anti-solvent precipitation for enhanced dissolution rate and antiplatelet activity of ticagrelor
Asmaa M. El-Deeb, Dalia H. Abdelkader, Gamal M. El Maghraby
Pharmaceutical Development and Technology (2025), pp. 1-16
Closed Access
Stratified Approaches to Antiplatelet Therapies Based on Platelet Reactivity Testing
Małgorzata Ostrowska, Jacek Kubica, Piotr Adamski, et al.
Frontiers in Cardiovascular Medicine (2019) Vol. 6
Open Access | Times Cited: 33
Role of P2Y Receptors in Platelet Extracellular Vesicle Release
Aleksandra Gąsecka, Sylwester Rogula, Ceren Eyileten, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 6065-6065
Open Access | Times Cited: 29
Why Not Dipyridamole: a Review of Current Guidelines and Re-evaluation of Utility in the Modern Era
Mahmoud Allahham, Amir Lerman, Dan Atar, et al.
Cardiovascular Drugs and Therapy (2021) Vol. 36, Iss. 3, pp. 525-532
Open Access | Times Cited: 25
Preparation and Evaluation of a Self-Emulsifying Drug Delivery System for Improving the Solubility and Permeability of Ticagrelor
Anam Aziz, Muhammad Zaman, Mahtab Ahmad Khan, et al.
ACS Omega (2024) Vol. 9, Iss. 9, pp. 10522-10538
Open Access | Times Cited: 3
Platelet Reactivity And Circulating Platelet-Derived Microvesicles Are Differently Affected By P2Y12 Receptor Antagonists
Bernadeta Chyrchel, Anna Drożdż, Dorota Długosz, et al.
International Journal of Medical Sciences (2019) Vol. 16, Iss. 2, pp. 264-275
Open Access | Times Cited: 29
A review of the effects of ticagrelor on adenosine concentration and its clinical significance
Mohammed Ahmed Akkaif, Mah Lee Ng, Muhamad Ali SK Abdul Kader, et al.
Pharmacological Reports (2021) Vol. 73, Iss. 6, pp. 1551-1564
Closed Access | Times Cited: 22
Randomized controlled trial protocol to investigate the antiplatelet therapy effect on extracellular vesicles (AFFECT EV) in acute myocardial infarction
Aleksandra Gąsecka, Rienk Nieuwland, Monika Budnik, et al.
Platelets (2018) Vol. 31, Iss. 1, pp. 26-32
Open Access | Times Cited: 25
Bioresorbable Vascular Scaffolds—Dead End or Still a Rough Diamond?
Mateusz P. Jeżewski, Michał Kubisa, Ceren Eyileten, et al.
Journal of Clinical Medicine (2019) Vol. 8, Iss. 12, pp. 2167-2167
Open Access | Times Cited: 22
Ticagrelor Removal by CytoSorb® in Patients Requiring Emergent or Urgent Cardiac Surgery: A UK-Based Cost-Utility Analysis
Mehdi Javanbakht, Miranda Trevor, Mohsen Rezaei Hemami‬, et al.
PharmacoEconomics - Open (2019) Vol. 4, Iss. 2, pp. 307-319
Open Access | Times Cited: 20
Impact of Crystal Habit on Solubility of Ticagrelor
Yan Ren, Jie Shen, Kaxi Yu, et al.
Crystals (2019) Vol. 9, Iss. 11, pp. 556-556
Open Access | Times Cited: 20
Plasma Trimethylamine-N-Oxide Is an Independent Predictor of Long-Term Cardiovascular Mortality in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome
Ceren Eyileten, Joanna Jarosz-Popek, Daniel Jakubik, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 17
Antiplatelet drugs and liver fibrosis
Pamela Czajka, Adam Przybyłkowski, A Nowak, et al.
Platelets (2021) Vol. 33, Iss. 2, pp. 219-228
Closed Access | Times Cited: 15
Comment on: “Comparison of Clinical Outcomes Between Ticagrelor and Clopidogrel in East-Asian Patients with Acute Coronary Syndrome: Large Cohort Study”
Chia Siang Kow, Abdullah Faiz Zaihan, Dinesh Sangarran Ramachandram, et al.
American Journal of Cardiovascular Drugs (2024) Vol. 24, Iss. 2, pp. 325-326
Closed Access | Times Cited: 1
Switching between P2Y12 antagonists – From bench to bedside
Aleksandra Gąsecka, Michał Konwerski, Justyna Pordzik, et al.
Vascular Pharmacology (2019) Vol. 115, pp. 1-12
Closed Access | Times Cited: 11
Page 1 - Next Page

Scroll to top